Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP682350.RA7TJ3yHaxc7ZL8Wdhc37njDytxFcvd9Lz9GKE4CD9zeY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP682350.RA7TJ3yHaxc7ZL8Wdhc37njDytxFcvd9Lz9GKE4CD9zeY130_assertion type Assertion NP682350.RA7TJ3yHaxc7ZL8Wdhc37njDytxFcvd9Lz9GKE4CD9zeY130_head.
- NP682350.RA7TJ3yHaxc7ZL8Wdhc37njDytxFcvd9Lz9GKE4CD9zeY130_assertion wasGeneratedBy ECO_0000203 NP682350.RA7TJ3yHaxc7ZL8Wdhc37njDytxFcvd9Lz9GKE4CD9zeY130_provenance.
- NP682350.RA7TJ3yHaxc7ZL8Wdhc37njDytxFcvd9Lz9GKE4CD9zeY130_assertion wasDerivedFrom befree-20140225 NP682350.RA7TJ3yHaxc7ZL8Wdhc37njDytxFcvd9Lz9GKE4CD9zeY130_provenance.
- NP682350.RA7TJ3yHaxc7ZL8Wdhc37njDytxFcvd9Lz9GKE4CD9zeY130_assertion SIO_000772 17959715 NP682350.RA7TJ3yHaxc7ZL8Wdhc37njDytxFcvd9Lz9GKE4CD9zeY130_provenance.
- NP682350.RA7TJ3yHaxc7ZL8Wdhc37njDytxFcvd9Lz9GKE4CD9zeY130_assertion evidence source_evidence_literature NP682350.RA7TJ3yHaxc7ZL8Wdhc37njDytxFcvd9Lz9GKE4CD9zeY130_provenance.
- NP682350.RA7TJ3yHaxc7ZL8Wdhc37njDytxFcvd9Lz9GKE4CD9zeY130_assertion description "[The MLH1 -93 variant allele was also over-represented in t-AML cases when compared to de novo AML cases (36.9%, n = 420) and healthy controls (36.3%, n = 952), and was associated with a significantly increased risk of developing t-AML (odds ratio 5.31, 95% confidence interval 1.40 to 20.15), but only in patients previously treated with a methylating agent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP682350.RA7TJ3yHaxc7ZL8Wdhc37njDytxFcvd9Lz9GKE4CD9zeY130_provenance.